166 related articles for article (PubMed ID: 12807242)
61. [Glassy cell carcinoma of the cervix].
Dieterle S; Mesrogli M; Günter HH; Kühnle H
Geburtshilfe Frauenheilkd; 1991 Jun; 51(6):484-5. PubMed ID: 1909675
[TBL] [Abstract][Full Text] [Related]
62. High dose rate brachytherapy for carcinoma of the uterine cervix: comparison of two different fractionation regimens.
Le Pechoux C; Akine Y; Sumi M; Tokuuye K; Ikeda H; Yajima M; Yamada T; Tanemura K; Tsunematsu R; Ohmi K
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):735-41. PubMed ID: 7860384
[TBL] [Abstract][Full Text] [Related]
63. Three-dimensional power Doppler ultrasound in cervical carcinoma: monitoring treatment response to radiotherapy.
Huang YF; Cheng YM; Wu YP; Chen HH; Hsu KF; Wu YH; Chou CY
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):84-92. PubMed ID: 22744872
[TBL] [Abstract][Full Text] [Related]
64. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.
Perez CA; Grigsby PW; Chao KS; Mutch DG; Lockett MA
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):307-17. PubMed ID: 9607346
[TBL] [Abstract][Full Text] [Related]
65. Simultaneous modulated accelerated radiotherapy in cervical cancer with retroperitoneal lymph node metastasis after radical hysterectomy and pelvic lymphadenectomy.
Li XL; Chen ZY; Cui YC; Sheng XG
Int J Gynecol Cancer; 2015 Jun; 25(5):903-9. PubMed ID: 25822099
[TBL] [Abstract][Full Text] [Related]
66. A ratio of apoptosis to mitosis, proliferation pattern and prediction of radiotherapy response in cervical carcinoma.
Gasinska A; Urbanski K; Gruchala A; Biesaga B; Kojs Z
Neoplasma; 2002; 49(6):379-86. PubMed ID: 12584585
[TBL] [Abstract][Full Text] [Related]
67. [Preoperative concurrent chemotherapy and radiation therapy in cervix cancer: preliminary results].
Kochbati L; Ben Ammar CN; Benna F; Hechiche M; Boussen H; Besbes M; Ben Abdallah M; Rahal K; Ben Ayed F; Ben Romdhane K; Maalej M
Tunis Med; 2005 Mar; 83(3):146-9. PubMed ID: 15929442
[TBL] [Abstract][Full Text] [Related]
68. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
[TBL] [Abstract][Full Text] [Related]
69. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
70. High-dose-rate afterloading brachytherapy in carcinoma of the cervix: an experience of 1992 patients.
Lorvidhaya V; Tonusin A; Changwiwit W; Chitapanarux I; Srisomboon J; Wanwilairat S; Chawapun N; Sukthomya V
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1185-91. PubMed ID: 10725630
[TBL] [Abstract][Full Text] [Related]
71. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma.
Levine EL; Renehan A; Gossiel R; Davidson SE; Roberts SA; Chadwick C; Wilks DP; Potten CS; Hendry JH; Hunter RD
Radiother Oncol; 1995 Oct; 37(1):1-9. PubMed ID: 8539450
[TBL] [Abstract][Full Text] [Related]
72. Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.
Tuipae S; Yanaranop M; Oniem N
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S117-24. PubMed ID: 22619897
[TBL] [Abstract][Full Text] [Related]
73. Radical radiotherapy in patients with cervix uteri carcinoma: experience of Ondokuz Mayis University.
Serarslan A; Gursel B; Meydan D; Ozbek Okumus N
BMC Cancer; 2019 Dec; 19(1):1208. PubMed ID: 31830953
[TBL] [Abstract][Full Text] [Related]
74. Treatment and outcome in cancer cervix patients treated between 1979 and 1994: a single institutional experience.
Shrivastava S; Mahantshetty U; Engineer R; Tongaonkar H; Kulkarni J; Dinshaw K
J Cancer Res Ther; 2013; 9(4):672-9. PubMed ID: 24518716
[TBL] [Abstract][Full Text] [Related]
75. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.
Tan LT; Jones B; Gee A; Kingston RE
Br J Radiol; 1997 Dec; 70(840):1259-69. PubMed ID: 9505845
[TBL] [Abstract][Full Text] [Related]
76. Results of the combination of external-beam and high-dose-rate intracavitary irradiation for patients with cervical carcinoma.
Kataoka M; Kawamura M; Nishiyama Y; Hamada K; Hamamoto K; Matsu-Ura S
Gynecol Oncol; 1992 Jan; 44(1):48-52. PubMed ID: 1730425
[TBL] [Abstract][Full Text] [Related]
77. Radiochemotherapy for patients with locally advanced cervical cancer: early results.
Ozsaran Z; Yalman D; Yürüt V; Aras A; Ozsaran A; Hanhan M; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(2):191-4. PubMed ID: 12701977
[TBL] [Abstract][Full Text] [Related]
78. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix.
Lee MY; Wu HG; Kim K; Ha SW; Kim JS; Kim IA; Lee HP
Gynecol Oncol; 2007 Jan; 104(1):95-9. PubMed ID: 16996117
[TBL] [Abstract][Full Text] [Related]
79. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
[TBL] [Abstract][Full Text] [Related]
80. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
